These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Synchronous resection of primary and liver metastases for neuroendocrine tumors. Gaujoux S; Gonen M; Tang L; Klimstra D; Brennan MF; D'Angelica M; Dematteo R; Allen PJ; Jarnagin W; Fong Y Ann Surg Oncol; 2012 Dec; 19(13):4270-7. PubMed ID: 22752376 [TBL] [Abstract][Full Text] [Related]
6. Total hepatectomy and liver transplantation for metastatic neuroendocrine tumors of the pancreas - a single center experience with ten patients. Lang H; Schlitt HJ; Schmidt H; Flemming P; Nashan B; Scheumann GF; Oldhafer KJ; Manns MP; Raab R Langenbecks Arch Surg; 1999 Aug; 384(4):370-7. PubMed ID: 10473858 [TBL] [Abstract][Full Text] [Related]
8. Hepatic metastases of gastroenteropancreatic neuroendocrine tumors: safe hepatic surgery. Jaeck D; Oussoultzoglou E; Bachellier P; Lemarque P; Weber JC; Nakano H; Wolf P World J Surg; 2001 Jun; 25(6):689-92. PubMed ID: 11376398 [TBL] [Abstract][Full Text] [Related]
9. Liver Transplantation for Neuroendocrine Tumors: What Have We Learned? Lim C; Lahat E; Osseis M; Sotirov D; Salloum C; Azoulay D Semin Liver Dis; 2018 Nov; 38(4):351-356. PubMed ID: 30357772 [TBL] [Abstract][Full Text] [Related]
10. Resection versus transplantation for liver metastases from neuroendocrine tumors. Coppa J; Pulvirenti A; Schiavo M; Romito R; Collini P; Di Bartolomeo M; Fabbri A; Regalia E; Mazzaferro V Transplant Proc; 2001; 33(1-2):1537-9. PubMed ID: 11267413 [No Abstract] [Full Text] [Related]
11. Determination of surgical margins in laparoscopic parenchyma-sparing hepatectomy of neuroendocrine tumors liver metastases using indocyanine green fluorescence imaging. Wang G; Luo Y; Qi W; Yuan C; Xiu D Surg Endosc; 2022 Jun; 36(6):4408-4416. PubMed ID: 35006372 [TBL] [Abstract][Full Text] [Related]
12. Hepatic parenchymal preserving technique in the management of diffuse bilateral neuroendocrine tumour liver metastases: a feasible approach. Nadler A; Cukier M; Milot L; Singh S; Law CH Can J Surg; 2014 Apr; 57(2):E2-8. PubMed ID: 24666455 [TBL] [Abstract][Full Text] [Related]
13. Liver resection versus other treatments for neuroendocrine tumours in patients with resectable liver metastases. Gurusamy KS; Ramamoorthy R; Sharma D; Davidson BR Cochrane Database Syst Rev; 2009 Apr; 2009(2):CD007060. PubMed ID: 19370671 [TBL] [Abstract][Full Text] [Related]
14. [Liver metastases from neuroendocrine tumours of the gastroenteropancreatic system--therapeutic strategies]. Auernhammer CJ; Jauch KW; Hoffmann JN Zentralbl Chir; 2009 Sep; 134(5):410-7. PubMed ID: 19757340 [TBL] [Abstract][Full Text] [Related]
19. Parenchymal-Sparing Versus Anatomic Liver Resection for Colorectal Liver Metastases: a Systematic Review. Moris D; Ronnekleiv-Kelly S; Rahnemai-Azar AA; Felekouras E; Dillhoff M; Schmidt C; Pawlik TM J Gastrointest Surg; 2017 Jun; 21(6):1076-1085. PubMed ID: 28364212 [TBL] [Abstract][Full Text] [Related]
20. Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor. Alagusundaramoorthy SS; Gedaly R World J Gastroenterol; 2014 Oct; 20(39):14348-58. PubMed ID: 25339822 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]